** = Publications listed in SCI/SSCI/Pubmed
** Krassnig, S; Leber, SL; Orthmann, A; Golob-Schwarzl, N; Huber, HJ; Wohlrab, C; Skofler, C; Pennauer, M; Raicht, A; Birkl-Toeglhofer, AM; Naumann, M; Mahdy-Ali, K; von, Campe, G; Leoni, M; Alcaniz, J; Hoffmann, J; Wälchli, T; Weis, S; Benesch, M; Haybaeck, J
Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy.
J Neurooncol. 2023; 165(1):91-100
Doi: 10.1007/s11060-023-04451-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Heugenhauser, J; Galijasevic, M; Mangesius, S; Goebel, G; Buchroithner, J; Erhart, F; Pichler, J; Widhalm, G; Stockhammer, G; Iglseder, S; Freyschlag, CF; Oberndorfer, S; Bordihn, K; von Campe, G; Czech, T; Surbock, B; Purkart, TU; Marosi, C; Felzmann, T; Nowosielski, M
MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy
CANCERS. 2022; 14(6): 1579
Doi: 10.3390/cancers14061579
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Heugenhauser, J; Galijasevic, M; Mangesius, S; Goebel, G; Buchroithner, J; Erhart, F; Pichler, J; Widhalm, G; Stockhammer, G; Iglseder, S; Freyschlag, C; Oberndorfer, S; Bordihn, K; Von Campe, G; Czech, T; Surbock, B; Purkart, TU; Marosi, C; Felzmann, T; Nowosielski, M
MRI response assessment in glioblastoma patients treated with dendritic cell-based immunotherapy
EUR J NEUROL. 2022; 29: 46-47.-8th Congress of the European-Academy-of-Neurology (EAN); JUN 25-28, 2022; ELECTR NETWORK.
[Poster]
Web of Science
** Muster, V; Raggam, RB; Urbanic-Purkart, T; Posch, F; Gutl, K; Rabensteiner, J; Pruller, F; von Campe, G; Rief, M; Brodmann, M; Gary, T
Lower-extremity deep vein thrombosis and bleeding complications in primary brain tumor patients: a prospective study
THROMB RES. 2022; 213: S16-S17.-11th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC); MAY 27-29, 2022; Bergamo, ITALY.
[Poster]
Web of Science
** Muster, V; Raggam, RB; Urbanic-Purkart, T; Posch, F; Gutl, K; Rabensteiner, J; Pruller, F; von Campe, G; Rief, M; Brodmann, M; Gary, T
LOWER-EXTREMITY DEEP VEIN THROMBOSIS AND BLEEDING COMPLICATIONS IN PRIMARY BRAIN TUMOR PATIENTS: A PROSPECTIVE STUDY
NEURO-ONCOLOGY. Meeting Abstracts. 2022; 24(S2):-17th Meeting of the European-Association-of-Neuro-Oncology; SEP 15-18, 2022; Vienna, AUSTRIA.
Doi: 10.1093/neuonc/noac174.190
[Poster]
Web of Science
FullText
FullText_MUG
** Krassnig, S; Wohlrab, C; Golob-Schwarzl, N; Raicht, A; Schatz, C; Birkl-Toeglhofer, AM; Skofler, C; Gantenbein, N; Leoni, M; Asslaber, M; Leber, SL; Mahdy-Ali, K; von Campe, G; Mayer, M; Borenich, A; Weis, S; Benesch, M; Haybaeck, J
A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy.
Cancers (Basel). 2021; 13(6):
Doi: 10.3390/cancers13061482
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Li, J; Gsaxner, C; Pepe, A; Morais, A; Alves, V; von Campe, G; Wallner, J; Egger, J
Synthetic skull bone defects for automatic patient-specific craniofacial implant design.
Sci Data. 2021; 8(1):36-36
Doi: 10.1038/s41597-021-00806-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Li, J; Pimentel, P; Szengel, A; Ehlke, M; Lamecker, H; Zachow, S; Estacio, L; Doenitz, C; Ramm, H; Shi, H; Chen, X; Matzkin, F; Newcombe, V; Ferrante, E; Jin, Y; Ellis, DG; Aizenberg, MR; Kodym, O; Spanel, M; Herout, A; Mainprize, JG; Fishman, Z; Hardisty, MR; Bayat, A; Shit, S; Wang, B; Liu, Z; Eder, M; Pepe, A; Gsaxner, C; Alves, V; Zefferer, U; von, Campe, G; Pistracher, K; Schafer, U; Schmalstieg, D; Menze, BH; Glocker, B; Egger, J
AutoImplant 2020-First MICCAI Challenge on Automatic Cranial Implant Design.
IEEE Trans Med Imaging. 2021; 40(9):2329-2342
Doi: 10.1109/TMI.2021.3077047
Web of Science
PubMed
FullText
FullText_MUG
** Li, J; von, Campe, G; Pepe, A; Gsaxner, C; Wang, E; Chen, X; Zefferer, U; Tödtling, M; Krall, M; Deutschmann, H; Schäfer, U; Schmalstieg, D; Egger, J
Automatic skull defect restoration and cranial implant generation for cranioplasty.
MED IMAGE ANAL. 2021; 73: 102171
Doi: 10.1016/j.media.2021.102171
Web of Science
PubMed
FullText
FullText_MUG
** Waldherr, L; Seitanidou, M; Jakesova, M; Handl, V; Honeder, S; Nowakowska, M; Tomin, T; Rad, MK; Schmidt, T; Distl, J; Birner-Gruenberger, R; Campe, G; Schafer, U; Berggren, M; Rinner, B; Asslaber, M; Ghaffari-Tabrizi-Wizsy, N; Patz, S; Simon, DT; Schindl, R
Targeted Chemotherapy of Glioblastoma Spheroids with an Iontronic Pump
ADV MATER TECHNOL-US. 2021; 2001302
Doi: 10.1002/admt.202001302
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Heugenhauser, J; Galijasevic, M; Mangesius, S; Buchroithner, J; Erhart, F; Pichler, J; Widhalm, G; Preusser, M; Stockhammer, G; Iglseder, S; Freyschlag, C; Oberndorfer, S; Bordihn, K; von Campe, G; Czech, T; Surboeck, B; Purkart, TU; Marosi, C; Felzmann, T; Nowosielski, M
RESPONSE ASSESSMENT IN GLIOBLASTOMA PATIENTS TREATED WITH DENDRITIC CELL-BASED IMMUNOTHERAPY: A COMPARATIVE ANALYSIS OF MACDONALD, RANO, MRANO, IRANO AND VOLUMETRIC MEASUREMENTS
NEURO-ONCOLOGY. Abstracts from the 2021 Society for Neuro-Oncology’s 26th Annual Scientific Meeting and Education Day. 2021; 23: 130-130.-26TH ANNUAL MEETING & EDUCATION DAY OF THE SOCIETY FOR NEURO-ONCOLOGY; NOV 18-21, 2021; Boston, USA.
[Poster]
Web of Science
** Freigang, S; Fresnoza, S; Mahdy Ali, K; Zaar, K; Jehna, M; Reishofer, G; Rammel, K; Studencnik, F; Ischebeck, A; von Campe, G
Impact of Priming on Effectiveness of TMS in Detecting Language-eloquent Brain Areas in Tumor Patients.
J Neurol Surg A Cent Eur Neurosurg. 2020; 81(2):111-129
Doi: 10.1055/s-0039-1698382
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Fresnoza, S; Christova, M; Purgstaller, S; Jehna, M; Zaar, K; Hoffermann, M; Mahdy Ali, K; Körner, C; Gallasch, E; von Campe, G; Ischebeck, A
Dissociating Arithmetic Operations in the Parietal Cortex Using 1 Hz Repetitive Transcranial Magnetic Stimulation: The Importance of Strategy Use.
Front Hum Neurosci. 2020; 14(11):271-271
Doi: 10.3389/fnhum.2020.00271
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jansma, JM; Rutten, GJ; Ramsey, LE; Snijders, TJ; Bizzi, A; Rosengarth, K; Dodoo-Schittko, F; Hattingen, E; de la Peña, MJ; von Campe, G; Jehna, M; Ramsey, NF
Automatic identification of atypical clinical fMRI results.
Neuroradiology. 2020; 62(12):1677-1688
Doi: 10.1007/s00234-020-02510-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jansma, JM; Rutten, GJ; Ramsey, LE; Snijders, TJ; Bizzi, A; Rosengarth, K; Dodoo-Schittko, F; Hattingen, E; de la Peña, MJ; von Campe, G; Jehna, M; Ramsey, NF
Correction to: Automatic identification of atypical clinical fMRI results.
Neuroradiology. 2020; 62(12):1723-1723
Doi: 10.1007/s00234-020-02565-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Darlix, A; Mandonnet, E; Freyschlag, CF; Pinggera, D; Forster, MT; Voss, M; Steinbach, J; Loughrey, C; Goodden, J; Banna, G; Di Blasi, C; Foroglou, N; Hottinger, AF; Baron, MH; Pallud, J; Duffau, H; Rutten, GJ; Almairac, F; Fontaine, D; Taillandier, L; Pessanha Viegas, C; Albuquerque, L; von Campe, G; Urbanic-Purkart, T; Blonski, M
Chemotherapy and diffuse low-grade gliomas: a survey within the European Low-Grade Glioma Network.
NEURO-ONCOL PRACT. 2019; 6(4): 264-273.
Doi: 10.1093/nop/npy051
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Buchroithner, J; Erhart, F; Pichler, J; Widhalm, G; Preusser, M; Stockhammer, G; Nowosielski, M; Iglseder, S; Freyschlag, CF; Oberndorfer, S; Bordihn, K; von Campe, G; Hoffermann, M; Ruckser, R; Rössler, K; Spiegl-Kreinecker, S; Fischer, MB; Czech, T; Visus, C; Krumpl, G; Felzmann, T; Marosi, C
Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.
Cancers (Basel). 2018; 10(10):
Doi: 10.3390/cancers10100372
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Freyschlag, CF; Krieg, SM; Kerschbaumer, J; Pinggera, D; Forster, MT; Cordier, D; Rossi, M; Miceli, G; Roux, A; Reyes, A; Sarubbo, S; Smits, A; Sierpowska, J; Robe, PA; Rutten, GJ; Santarius, T; Matys, T; Zanello, M; Almairac, F; Mondot, L; Jakola, AS; Zetterling, M; Rofes, A; von Campe, G; Guillevin, R; Bagatto, D; Lubrano, V; Rapp, M; Goodden, J; De Witt Hamer, PC; Pallud, J; Bello, L; Thomé, C; Duffau, H; Mandonnet, E
Imaging practice in low-grade gliomas among European specialized centers and proposal for a minimum core of imaging.
J Neurooncol. 2018;
Doi: 10.1007/s11060-018-2916-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Klughammer, J; Kiesel, B; Roetzer, T; Fortelny, N; Nemc, A; Nenning, KH; Furtner, J; Sheffield, NC; Datlinger, P; Peter, N; Nowosielski, M; Augustin, M; Mischkulnig, M; Ströbel, T; Alpar, D; Ergüner, B; Senekowitsch, M; Moser, P; Freyschlag, CF; Kerschbaumer, J; Thomé, C; Grams, AE; Stockhammer, G; Kitzwoegerer, M; Oberndorfer, S; Marhold, F; Weis, S; Trenkler, J; Buchroithner, J; Pichler, J; Haybaeck, J; Krassnig, S; Mahdy Ali, K; von Campe, G; Payer, F; Sherif, C; Preiser, J; Hauser, T; Winkler, PA; Kleindienst, W; Würtz, F; Brandner-Kokalj, T; Stultschnig, M; Schweiger, S; Dieckmann, K; Preusser, M; Langs, G; Baumann, B; Knosp, E; Widhalm, G; Marosi, C; Hainfellner, JA; Woehrer, A; Bock, C
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space.
Nat Med. 2018; 24(10):1611-1624
Doi: 10.1038/s41591-018-0156-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Egger, J; Gall, M; Tax, A; Ücal, M; Zefferer, U; Li, X; von Campe, G; Schäfer, U; Schmalstieg, D; Chen, X
Interactive reconstructions of cranial 3D implants under MeVisLab as an alternative to commercial planning software.
PLoS One. 2017; 12(3):e0172694-e0172694
Doi: 10.1371/journal.pone.0172694
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hoffermann, M; Bruckmann, L; Mahdy Ali, K; Zaar, K; Avian, A; von Campe, G
Pre- and postoperative neurocognitive deficits in brain tumor patients assessed by a computer based screening test.
J Clin Neurosci. 2017; 36: 31-36.
Doi: 10.1016/j.jocn.2016.10.030
Web of Science
PubMed
FullText
FullText_MUG
** Jehna, M; Becker, J; Zaar, K; von Campe, G; Mahdy Ali, K; Reishofer, G; Payer, F; Synowitz, M; Fazekas, F; Enzinger, C; Deutschmann, H
Symmetry of the arcuate fasciculus and its impact on language performance of patients with brain tumors in the language-dominant hemisphere.
J Neurosurg. 2017; 127(6):1407-1416
Doi: 10.3171/2016.9.JNS161281
Web of Science
PubMed
FullText
FullText_MUG
** Katschnig, M; Arbeiter, F; Haar, B; van Campe, G; Holzer, C
Cranial Polypropylene Implants by Fused Filament Fabrication
ADV ENG MATER. 2017; 19(4): UNSP 1600676
Doi: 10.1002/adem.201600676
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Mandonnet, E; Wager, M; Almairac, F; Baron, MH; Blonski, M; Freyschlag, CF; Barone, F; Fontaine, D; Pallud, J; Hegi, M; Viegas, C; Zetterling, M; Spena, G; Goodden, J; Rutten, GJ; Taillandier, L; Foroglu, N; Darlix, A; Skrap, M; Martino, J; von Campe, G; Madadaki, C; Gayat, E; de Witt Hamer, P; Gil Robles, S; Sarubbo, S; Santarius, T; Bello, L; Forster, MT; Duffau, H
Survey on current practice within the European Low-Grade Glioma Network: where do we stand and what is the next step?
Neurooncol Pract. 2017; 4(4):241-247
Doi: 10.1093/nop/npw031
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** European Low-Grade Glioma Network (see appendix for full list of contributors). Electronic address: elggn2006@gmail.com
Evidence-based management of adult patients with diffuse glioma.
LANCET ONCOL. 2017; 18(8): e429-e429.
Doi: 10.1016/S1470-2045(17)30510-7
Web of Science
PubMed
FullText
FullText_MUG
** Krassnig, S; Orthmann, A; Toeglhofer, AM; Wohlrab, C; Golob-Schwarzl, N; Wodlej, C; Pennauer, M; Raicht, A; Ali, KM; von Campe, G; Gogg-Kamerer, M; Logi, M; Sygulla, S; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J
Eukaryotic initiation factors might not only represent novel targets for glioma therapies but might also monitor drug effectiveness
VIRCHOWS ARCH. 2017; 471: S46-S46.
[Oral Communication]
Web of Science
** Seule, M; Sikorski, C; Sakowitz, O; von Campe, G; Santos, E; Orakcioglu, B; Unterberg, A; Keller, E
Evaluation of a New Brain Tissue Probe for Intracranial Pressure, Temperature, and Cerebral Blood Flow Monitoring in Patients with Aneurysmal Subarachnoid Hemorrhage.
Neurocrit Care. 2016; 25(2):193-200
Doi: 10.1007/s12028-016-0284-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hoffermann, M; Bruckmann, L; Kariem Mahdy, A; Asslaber, M; Payer, F; von Campe, G
Treatment results and outcome in elderly patients with glioblastoma multiforme--a retrospective single institution analysis.
Clin Neurol Neurosurg. 2015; 128(2):60-69
Doi: 10.1016/j.clineuro.2014.11.006
Web of Science
PubMed
FullText
FullText_MUG
** Ernst, C; Krassnig, S; Golob-Schwarzl, N; Asslaber, M; Raicht, A; Lederer, E; Spilka, R; Von Campe, G; Orthmann, A; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J
Eukaryotic initiation factors and their contribution to gliomas might be relevant for the development of new therapies
VIRCHOWS ARCH. . 2015; 467: S40-S40.
[Oral Communication]
Web of Science
** Woehrer, A; Hackl, M; Waldhör, T; Weis, S; Pichler, J; Olschowski, A; Buchroithner, J; Maier, H; Stockhammer, G; Thomé, C; Haybaeck, J; Payer, F; von Campe, G; Kiefer, A; Würtz, F; Vince, GH; Sedivy, R; Oberndorfer, S; Marhold, F; Bordihn, K; Stiglbauer, W; Gruber-Mösenbacher, U; Bauer, R; Feichtinger, J; Reiner-Concin, A; Grisold, W; Marosi, C; Preusser, M; Dieckmann, K; Slavc, I; Gatterbauer, B; Widhalm, G; Haberler, C; Hainfellner, JA; Austrian Brain Tumour Registry
Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry.
Br J Cancer. 2014; 110(2):286-296
Doi: 10.1038/bjc.2013.714
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Buchroithner, J; Pichler, J; Marosi, C; Widhalm, G; Seiz-Rosenhagen, M; Novosielski, M; Oberndorfer, S; Ruckser, R; Rossler, K; Azizi, A; von Campe, G; Bordihn, K; Felzmann, T
Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy
INT J CLIN PHARM TH. 2014; 52(1):76-77.-Extended Abstract, CESAR Annual Meeting; JUN 27-29, 2013; Tübingen, GERMANY.
Doi: 10.5414/CPXCES13EA02
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Felzmann, T; Buchroithner, J; Marosi, C; Nowosieiski, M; von Campe, G; Oberndorfer, S; Ruckser, R; Bordihn, K; Azizi, AA; Roessler, K; Pichler, J; Stockhammer, G; Widhaim, G; Thome, C; Muehlbauer, M; Loyoddin, M; Czech, T; Fischer, MB; Gabriel, C; Schennach, H
A randomized clinical trial for the treatment of glioblastoma mulliforme with the individualized dendritic cell based cancer immunotherapy AV0113
J CLIN ONCOL. 2014; 32(15):-50th Annual Meeting of the American-Society-of-Clinical-Oncology; MAY 30-JUN 03, 2014; Chicago, IL.
Doi: 10.1200/jco.2014.32.15_suppl.2052
[Poster]
Web of Science
FullText
FullText_MUG
** Felzmann, T; Buchroithner, J; Marosi, C; Nowosielski, M; von Campe, G; Oberndorfer, S; Ruckser, R; Rossler, K; Azizi, A; Bordihn, K
Dendritic cell-based cancer immune therapy for glioblastoma multiforme: First trends from a randomised efficacy study
ONKOLOGIE. . 2013; 36(S7):95-95.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 18-22, 2013; Vienna, AUSTRIA.
[Oral Communication]
Web of Science
** Felzmann, T; Buchroithner, J; Marosi, C; Nowosielsky, M; Oberndorfer, S; Ruckser, R; Rossler, K; Azizi, A; von Campe, G; Bordihn, K; The Austrian GBM-Vax consortium
First interim analysis of a randomized study to evaluate safety and efficacy of individualized dendritic cell-based cancer immune therapy for glioblastoma multiforme.
CANCER RES. Abstract Nr 4658 . 2013; 73 (8 Suppl): -Proceedings of the 104th Annual Meeting of the American Association for Cancer Research (AACR); APR 06-10, 2013; Washington, DC.
Doi: 10.1158/1538-7445.AM2013-4658
[Poster]
Web of Science
FullText
FullText_MUG
** Hoffermann, M; Bruckmann, L; Ali, KM; Asslaber, M; Payer, F; von Campe, G
SPECIFIC TREATMENT CONSIDERATIONS AND OUTCOME DATA IN ELDERLY GLIOMA PATIENTS - A SINGLE CENTER EXPERIENCE
NEURO-ONCOLOGY. . 2013; 15 (Suppl. 3): 220-220.-4th Quadrennial Meeting of the World-Federation-of-Neuro-Oncology (WFNO) held in conjunction with the 18th Annual Meeting of the Society-for-Neuro-Oncology (SNO); NOV 21-24, 2013; San Francisco, CA.
[Poster]
Web of Science
** Haybaeck, J; von Campe, G; Hainfellner, JA
Rapid frozen sections in neuropathology.
Pathologe. 2012; 33(5):379-388
Doi: 10.1007/s00292-012-1604-x
Web of Science
PubMed
FullText
FullText_MUG
** von Campe, G; Moschopulos, M; Hefti, M
5-Aminolevulinic acid-induced protoporphyrin IX fluorescence as immediate intraoperative indicator to improve the safety of malignant or high-grade brain tumor diagnosis in frameless stereotactic biopsies.
Acta Neurochir (Wien). 2012; 154(4):585-588
Doi: 10.1007/s00701-012-1290-8
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hefti, M; von Campe, G; Schneider, C; Roelcke, U; Landolt, H
Multicentric tumor manifestations of high grade gliomas: independent proliferation or hallmark of extensive disease?
Cen Eur Neurosurg. 2010; 71(1): 20-25.
Doi: 10.1055/s-0029-1241190
Web of Science
PubMed
FullText
FullText_MUG
** Hefti, M; von Campe, G; Schneider, C; Roelcke, U; Landolt, H
Multicentric Tumor Manifestations of High Grade Gliomas: Independent Proliferation or Hallmark of Extensive Disease? (vol 71, pg 20, 2010)
CENT EUR NEUROSURG. 2010; 71(2): 103-103.
Doi: 10.1055/s-0030-1254915
Web of Science
FullText
FullText_MUG
** Hefti, M; von Campe, G; Moschopulos, M; Siegner, A; Looser, H; Landolt, H
5-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: a one-year experience at a single institutuion.
Swiss Med Wkly. 2008; 138(11-12): 180-185.
[OPEN ACCESS]
Web of Science
PubMed
FullText
** von Campe, G; Regli, F; Bogousslavsky, J
Heralding manifestations of basilar artery occlusion with lethal or severe stroke.
J Neurol Neurosurg Psychiatry. 2003; 74(12): 1621-1626.
Doi: 10.1136/jnnp.74.12.1621
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** de Lanerolle, NC; Eid, T; von Campe, G; Kovacs, I; Spencer, DD; Brines, M
Glutamate receptor subunits GluR1 and GluR2/3 distribution shows reorganization in the human epileptogenic hippocampus.
Eur J Neurosci. 1998; 10(5): 1687-1703.
Doi: 10.1046/j.1460-9568.1998.00171.x
Web of Science
PubMed
FullText
FullText_MUG
** von Campe, G; Spencer, DD; de Lanerolle, NC
Morphology of dentate granule cells in the human epileptogenic hippocampus.
Hippocampus. 1997; 7(5): 472-488.
Doi: 10.1002/(SICI)1098-1063(1997)7:5<472::AID-HIPO4>3.0.CO;2-J
Web of Science
PubMed
FullText
FullText_MUG
** von Campe, G; Regli, F; Confavreux, C; Aimard, G
Bilateral deafness, an initial manifestation of meningeal carcinomatosis
Rev Neurol (Paris). 1992; 148(2): 133-138.
Web of Science
PubMed
Google Scholar